BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 30148742)

  • 1. A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract.
    Pors J; Cheng A; Leo JM; Kinloch MA; Gilks B; Hoang L
    Am J Surg Pathol; 2018 Dec; 42(12):1596-1606. PubMed ID: 30148742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Expression Patterns of GATA3 in Uterine Mesonephric and Nonmesonephric Lesions.
    Roma AA; Goyal A; Yang B
    Int J Gynecol Pathol; 2015 Sep; 34(5):480-6. PubMed ID: 25851711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract.
    Howitt BE; Emori MM; Drapkin R; Gaspar C; Barletta JA; Nucci MR; McCluggage WG; Oliva E; Hirsch MS
    Am J Surg Pathol; 2015 Oct; 39(10):1411-9. PubMed ID: 26135559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesonephric carcinosarcoma involving uterine cervix and vagina: report of 2 cases with immunohistochemical positivity For PAX2, PAX8, and GATA-3.
    Roma AA
    Int J Gynecol Pathol; 2014 Nov; 33(6):624-9. PubMed ID: 25272303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic Characteristics of Mesonephric Adenocarcinomas and Mesonephric-like Adenocarcinomas in the Gynecologic Tract: A Multi-institutional Study.
    Pors J; Segura S; Chiu DS; Almadani N; Ren H; Fix DJ; Howitt BE; Kolin D; McCluggage WG; Mirkovic J; Gilks B; Park KJ; Hoang L
    Am J Surg Pathol; 2021 Apr; 45(4):498-506. PubMed ID: 33165093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma.
    McCluggage WG; Vosmikova H; Laco J
    Int J Gynecol Pathol; 2020 Jan; 39(1):84-92. PubMed ID: 30575604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesonephric adenocarcinoma of the uterine corpus.
    Wu H; Zhang L; Cao W; Hu Y; Liu Y
    Int J Clin Exp Pathol; 2014; 7(10):7012-9. PubMed ID: 25400789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β.
    Kenny SL; McBride HA; Jamison J; McCluggage WG
    Am J Surg Pathol; 2012 Jun; 36(6):799-807. PubMed ID: 22456609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract.
    Mirkovic J; McFarland M; Garcia E; Sholl LM; Lindeman N; MacConaill L; Dong F; Hirsch M; Nucci MR; Quick CM; Crum CP; McCluggage WG; Howitt BE
    Am J Surg Pathol; 2018 Feb; 42(2):227-233. PubMed ID: 28984674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report.
    Yano M; Shintani D; Katoh T; Hamada M; Ito K; Kozawa E; Hasegawa K; Yasuda M
    Diagn Pathol; 2019 Jun; 14(1):54. PubMed ID: 31174566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Immunohistochemical Analyses Using Markers for Mesonephric, Endometrioid and Serous Tumors.
    Kim H; Na K; Bae GE; Kim HS
    Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrauterine Mesonephric-like Neoplasms: Expanding the Morphologic Spectrum.
    Deolet E; Arora I; Van Dorpe J; Van der Meulen J; Desai S; Van Roy N; Kaur B; Van de Vijver K; McCluggage WG
    Am J Surg Pathol; 2022 Jan; 46(1):124-133. PubMed ID: 34183523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Immunohistochemical Analysis of Mesonephric Marker Expression in Low-grade Endometrial Endometrioid Carcinoma.
    Lee Y; Choi S; Kim HS
    Int J Gynecol Pathol; 2024 May; 43(3):221-232. PubMed ID: 37566876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesonephric-like Endometrial Carcinoma: Results From Immunohistochemical Screening of 300 Endometrial Carcinomas and Carcinosarcomas for This Often Overlooked and Potentially Aggressive Entity.
    Mills AM; Jenkins TM; Howitt BE; Fan J; Ring KL; Cook I
    Am J Surg Pathol; 2022 Jul; 46(7):921-932. PubMed ID: 35195579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesonephric Adenocarcinoma of the Uterine Corpus: A Report on 2 Cases With Comparison to Its Cervical Counterpart.
    Liang Y; Shi H; Zhu X; Yu M; Zhang X
    Int J Gynecol Pathol; 2020 Nov; 39(6):546-551. PubMed ID: 31985582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesonephric (Wolffian-derived) Adenocarcinoma of the Female Urethra.
    Paner GP; Lopez-Beltran A; Amin MB
    Am J Surg Pathol; 2021 Apr; 45(4):543-549. PubMed ID: 33284194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
    Stolnicu S; Barsan I; Hoang L; Patel P; Chiriboga L; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
    Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesonephric Adenocarcinoma of the Uterine Corpus: A Case Report and Diagnostic Pitfall.
    Kim SS; Nam JH; Kim GE; Choi YD; Choi C; Park CS
    Int J Surg Pathol; 2016 Apr; 24(2):153-8. PubMed ID: 26510860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Value of Immunostaining for Thyroid Transcription Factor 1 (TTF1) and Paired Box 8 (PAX8) in Distinguishing Pulmonary Metastases of Mesonephric and Mesonephric-like Adenocarcinomas from Primary Lung Adenocarcinomas.
    Ji N; Lee Y; Lee SH; Kim HS
    Anticancer Res; 2024 May; 44(5):2159-2170. PubMed ID: 38677751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.